Difficulty: Medium
Average Score: 64%
Practice
The first-line treatment for children with Vibrio cholera is
Correct answer
A
Rationale
The correct answer is A) azithromycin for the first-line treatment of children with Vibrio cholera due to its efficacy and safety profile in this population. Azithromycin is a macrolide antibiotic that is effective against Vibrio cholera and is well-tolerated in pediatric patients. It is often preferred over other antibiotics due to its broad spectrum of activity and minimal side effects.
Option B) ciprofloxacin is not the first-line treatment for Vibrio cholera in children because of concerns about its safety profile, especially in young patients. Ciprofloxacin is associated with potential adverse effects on growing cartilage and should be avoided in pediatric populations whenever possible.
Option C) doxycycline is not recommended for children with Vibrio cholera as it can cause permanent discoloration of teeth and is contraindicated in pediatric patients under the age of 8 years due to its effects on bone growth and development.
Option D) ampicillin is not the first-line treatment for Vibrio cholera as this bacterium is often resistant to penicillin-based antibiotics. Using ampicillin as a treatment could be ineffective and potentially worsen the infection by promoting antibiotic resistance.
In an educational context, understanding the appropriate first-line treatment for pediatric gastrointestinal infections like Vibrio cholera is crucial for nurses and healthcare providers working with children. By knowing the most effective and safe treatment options, healthcare professionals can ensure better outcomes for pediatric patients with gastrointestinal disorders and prevent potential complications associated with inappropriate antibiotic use.
Option B) ciprofloxacin is not the first-line treatment for Vibrio cholera in children because of concerns about its safety profile, especially in young patients. Ciprofloxacin is associated with potential adverse effects on growing cartilage and should be avoided in pediatric populations whenever possible.
Option C) doxycycline is not recommended for children with Vibrio cholera as it can cause permanent discoloration of teeth and is contraindicated in pediatric patients under the age of 8 years due to its effects on bone growth and development.
Option D) ampicillin is not the first-line treatment for Vibrio cholera as this bacterium is often resistant to penicillin-based antibiotics. Using ampicillin as a treatment could be ineffective and potentially worsen the infection by promoting antibiotic resistance.
In an educational context, understanding the appropriate first-line treatment for pediatric gastrointestinal infections like Vibrio cholera is crucial for nurses and healthcare providers working with children. By knowing the most effective and safe treatment options, healthcare professionals can ensure better outcomes for pediatric patients with gastrointestinal disorders and prevent potential complications associated with inappropriate antibiotic use.